Treatment Practices for Infantile Epileptic Spasms Syndrome: Consensus and Variation in Major Pediatric Epilepsy Centers - 04/12/25
, Akshat Katyayan, MD b, Chellamani Harini, MD a, Shaun A. Hussain, MD c, Sonam Bhalla, MD d, Avantika Singh, MD e, Stephanie Donatelli, MD a, Amanda G. Sandoval Karamian, MD f, Debopam Samanta, MD g, Deepa Sirsi, MD h, Eva Catenaccio, MD i, Maria A. Planchart Ferretto, MD a, Liu Lin Thio, MD, PhD j, Senyene E. Hunter, MD, PhD k, Pavuluri Spriha, MD l, Chethan K. Rao, DO, MS m, Sonal Bhatia, MD n, Gozde Erdemir, MD o, Daniel W. Shrey, MD p, Adam L. Numis, MD qAbstract |
Background |
Infantile epileptic spasms syndrome (IESS) is a developmental and epileptic encephalopathy that requires prompt, effective treatment to optimize outcomes. While the first therapies for IESS with adrenocorticotrophic hormone, prednisolone, or vigabatrin are widely established as a standard, we hypothesized that the treatment protocols of how these therapies should be implemented varied across medical centers.
Methods |
The Pediatric Epilepsy Research Consortium Infantile Spasms Special Interest Group distributed a REDCap survey to 75 US epilepsy centers. Predefined treatment pathway characteristics were extracted and compared. Standard therapy regimens were defined before data collection.
Results |
Thirty-six centers participated (48% completion rate). Most (89%, n = 32) had IESS treatment pathways, with 72% (n = 23) influenced by insurance barriers such as prior authorizations. Of these, 75% (n = 24) contributed pathways for analysis. Most protocols (88%, n = 21) recommended a standard treatment course for new-onset IESS. Of these, 63% (n = 15) endorsed a sequential approach to using hormonal therapy and vigabatrin, while 17% (n = 4) recommended combination therapy with both for all children. Thirteen centers (54%) provided recommendations for treating persistent epileptic spasms. Approaches to side-effect mitigation varied widely, with gastrointestinal prophylaxis and blood pressure control being the most common (79%, n = 19). Half of the pathways mentioned ketogenic diet (58%) or epilepsy surgery (46%).
Conclusions |
While there was broad consensus regarding first and second therapy treatment for IESS, variability existed in using sequential versus combination therapy, third therapies, and adverse event monitoring. These findings will guide next research steps in defining key questions on sequential versus combination therapy, third line therapy, and adverse event monitoring in order to develop a standardized consensus-driven treatment protocol for IESS in the future.
Le texte complet de cet article est disponible en PDF.Keywords : Infantile epileptic spasms syndrome (IESS), Infantile spasms (IS), West Syndrome, Pediatric Epilepsy Research Consortium (PERC)
Plan
Vol 174
P. 46-53 - janvier 2026 Retour au numéro
Article précédent
- Involvement of the Posterior Visual Pathway Correlates With Higher-Order Visual Impairment in Childhood Stroke Participants Detected by Virtual Reality/Eye-Tracking Paradigm
- Emily Da Cruz, Diana Tambala, Anna Lynch, Claire Manley, Melissa Bambery, Daniel Kelly, Carrie Chui, Kenda Alhadid, Alyssa W. Sullivan, Julie Grieco, Benjamin Ondeck, Arne Lauer, Lotfi B. Merabet, Patricia L. Musolino
- Application of Delphi Method-Based Definition of Treatment-Refractory Tourette Disorder in a Large Italian Clinical Cohort of Children and Adolescents
- Adriana Prato, Rita Barone, Maria Chiara Milana, Lara Cirnigliaro, Davide Martino, Renata Rizzo
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?